サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1609826

日本の生殖補助医療市場レポート：製品、タイプ、最終用途、地域別、2024年～2032年

Japan Assisted Reproductive Technology Market Report by Product, Type (In-Vitro Fertilization, Artificial Insemination), End Use, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 116 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
日本の生殖補助医療市場レポート：製品、タイプ、最終用途、地域別、2024年～2032年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 116 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の生殖補助医療市場の市場規模は2023年に32億9,410万米ドルに達しました。今後、IMARC Groupは、2032年の市場規模は60億5,610万米ドルに達し、2024～2032年の成長率（CAGR）は7.00%になると予測しています。日本における不妊症の有病率の増加、政府による支援措置の導入、ARTにおける最近の技術進歩、不妊治療に対する認識と社会的受容の高まりが、市場を牽引する主な要因となっています。

本レポートで扱う主な質問

  • 日本の生殖補助医療市場はこれまでどのように推移してきたか、また今後どのように推移していくか？
  • COVID-19の日本の生殖補助医療市場への影響は？
  • 日本の生殖補助医療市場の製品別構成比は？
  • 日本の生殖補助医療市場のタイプ別の内訳は？
  • 日本の生殖補助医療市場の最終用途別の内訳は？
  • 日本の生殖補助医療市場のバリューチェーンにはどのような段階がありますか？
  • 日本の生殖補助医療技術における主な促進要因と課題は何か？
  • 日本の生殖補助医療市場の構造と主要プレーヤーは？
  • 生殖補助医療における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の生殖補助医療市場-イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の生殖補助医療市場情勢

  • 過去および現在の市場動向（2018～2023年）
  • 市場予測（2024年～2032年）

第6章 日本の生殖補助医療市場- 製品別内訳

  • 機器
  • アクセサリーと使い捨て
  • 試薬と培地

第7章 日本の生殖補助医療市場- タイプ別内訳

  • 体外受精（IVF）
  • 人工授精

第8章 日本の生殖補助医療市場- 最終用途別の内訳

  • 不妊治療クリニックおよびその他の施設
  • 病院等

第9章 日本の生殖補助医療市場-競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第10章 主要企業のプロファイル

第11章 日本の生殖補助医療市場- 業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第12章 付録

目次
Product Code: SR112024A19599

Japan assisted reproductive technology market size reached US$ 3,294.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,056.1 Million by 2032, exhibiting a growth rate (CAGR) of 7.00% during 2024-2032. The increasing prevalence of infertility in Japan, introduction of supportive measures by the government, recent technological advancements in ART, and rising awareness and societal acceptance of infertility treatment represent some of the key factors driving the market.

Assisted reproductive technology (ART) refers to medical procedures used primarily to address infertility. It includes a variety of methodologies, such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, and fertility medication. ART possesses several features, like the ability to bypass physiological hurdles to fertilization, enhance gamete quality, or preserve fertility. It is comprised of medical expertise, sophisticated laboratories, legal frameworks, and ethical governance. ART is widely used by infertile couples, single individuals, and the lesbian and gay community desiring parenthood. It also finds applications in genetic disorder prevention, family balancing, surrogacy facilitation, and fertility preservation for cancer patients. ART offers a higher chance of conception, control over timing, the possibility of screening for genetic diseases, and increased knowledge about one's fertility. In addition to this, it provides several advantages, such as options for multiple pregnancy attempts and allowing same-sex couples or single parents to conceive.

Japan Assisted Reproductive Technology Market Trends:

The increasing prevalence of infertility in Japan due to lifestyle changes and the rising geriatric population represents one of the key factors propelling the market growth. Additionally, the introduction of supportive measures by the government, such as subsidizing ART procedures to encourage couples to seek treatment, is boosting the market growth. Besides this, recent technological advancements in ART that are enhancing success rates, thus boosting its adoption, are catalyzing the market growth. Furthermore, the rising awareness and social acceptance of infertility treatments are contributing to the market growth. In addition, the ongoing improvements in the regulatory framework, which provide safety assurances to potential patients, are driving the market growth. Apart from this, the increasing disposable incomes in Japan, allowing more individuals to afford often expensive treatments, such as ART, is bolstering the market growth. Moreover, the escalating investment in research and innovation by key players to develop effective treatment options for infertility is positively influencing the market growth. Along with this, the rising collaborations between Japanese and international fertility clinics to expand access to best practices and advanced treatments are supporting the market growth. In line with this, the increasing societal pressure and desire for family creation in Japan's culture is fueling the market growth. Additionally, the emergence of fertility tourism, allowing people to visit Japan for high-quality ART services, is stimulating the market growth. Furthermore, the extension of ART services to a broader demographic, including older women and single individuals, which is opening new segments, is accelerating the market growth. Besides this, recent advancements in genetic screening technologies that are making ART safer and more reliable are strengthening the market growth across the country.

Japan Assisted Reproductive Technology Market Segmentation:

Product Insights:

  • Instrument
  • Sperm Separation System
  • Cryosystem
  • Incubator
  • Imaging System
  • Ovum Aspiration Pump
  • Cabinet
  • Micromanipulator
  • Laser Systems
  • Others
  • Accessory and Disposable
  • Reagents and Media
  • Cryopreservation Media
  • Semen Processing Media
  • Ovum Processing Media
  • Embryo Culture Media

Type Insights:

  • In-Vitro Fertilization (IVF)
  • Fresh Donor
  • Frozen Donor
  • Fresh Non-Donor
  • Frozen Non-Donor
  • Artificial Insemination
  • Intrauterine Insemination
  • Intracervical Insemination
  • Intravaginal Insemination
  • Intratubal Insemination

End Use Insights:

  • Fertility Clinics and Other Facilities
  • Hospitals and Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan assisted reproductive technology market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan assisted reproductive technology market?
  • What is the breakup of the Japan assisted reproductive technology market on the basis of product?
  • What is the breakup of the Japan assisted reproductive technology market on the basis of type?
  • What is the breakup of the Japan assisted reproductive technology market on the basis of end use?
  • What are the various stages in the value chain of the Japan assisted reproductive technology market?
  • What are the key driving factors and challenges in the Japan assisted reproductive technology?
  • What is the structure of the Japan assisted reproductive technology market and who are the key players?
  • What is the degree of competition in the Japan assisted reproductive technology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Assisted Reproductive Technology Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Assisted Reproductive Technology Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Assisted Reproductive Technology Market - Breakup by Product

  • 6.1 Instrument
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Sperm Separation System
      • 6.1.3.2 Cryosystem
      • 6.1.3.3 Incubator
      • 6.1.3.4 Imaging System
      • 6.1.3.5 Ovum Aspiration Pump
      • 6.1.3.6 Cabinet
      • 6.1.3.7 Micromanipulator
      • 6.1.3.8 Laser Systems
      • 6.1.3.9 Others
    • 6.1.4 Market Forecast (2024-2032)
  • 6.2 Accessory and Disposable
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)
  • 6.3 Reagents and Media
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2018-2023)
    • 6.3.3 Market Segmentation
      • 6.3.3.1 Cryopreservation Media
      • 6.3.3.2 Semen Processing Media
      • 6.3.3.3 Ovum Processing Media
      • 6.3.3.4 Embryo Culture Media
    • 6.3.4 Market Forecast (2024-2032)

7 Japan Assisted Reproductive Technology Market - Breakup by Type

  • 7.1 In-Vitro Fertilization (IVF)
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Segmentation
      • 7.1.3.1 Fresh Donor
      • 7.1.3.2 Frozen Donor
      • 7.1.3.3 Fresh Non-Donor
      • 7.1.3.4 Frozen Non-Donor
    • 7.1.4 Market Forecast (2024-2032)
  • 7.2 Artificial Insemination
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Segmentation
      • 7.2.3.1 Intrauterine Insemination
      • 7.2.3.2 Intracervical Insemination
      • 7.2.3.3 Intravaginal Insemination
      • 7.2.3.4 Intratubal Insemination
    • 7.2.4 Market Forecast (2024-2032)

8 Japan Assisted Reproductive Technology Market - Breakup by End Use

  • 8.1 Fertility Clinics and Other Facilities
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Hospitals and Others
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)

9 Japan Assisted Reproductive Technology Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Assisted Reproductive Technology Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix